Rejoinder to discussion on Is group testing ready for prime-time in disease identification?
Stat Med
.
2021 Jul 30;40(17):3892-3894.
doi: 10.1002/sim.9033.
Authors
Gregory Haber
1
,
Yaakov Malinovsky
2
,
Paul S Albert
1
Affiliations
1
Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
2
Department of Mathematics and Statistics, University of Maryland, Baltimore County, Baltimore, Maryland, USA.
PMID:
34251036
PMCID:
PMC8441689
DOI:
10.1002/sim.9033
No abstract available
Publication types
Comment